SARS-CoV-2 Seroprevalence in Germany.

Gornyk, Daniela; Harries, Manuela; Glöckner, Stephan; Strengert, Monika; Kerrinnes, Tobias; Heise, Jana-Kristin; Maaß, Henrike; Ortmann, Julia; Kessel, Barbora; Kemmling, Yvonne; Lange, Berit; Krause, Gérard

Gornyk, Daniela; Harries, Manuela; Glöckner, Stephan; Strengert, Monika; Kerrinnes, Tobias; Heise, Jana-Kristin; Maaß, Henrike; Ortmann, Julia; Kessel, Barbora; Kemmling, Yvonne; Lange, Berit; Krause, Gérard.

Afiliação

Gornyk D; Department of Epidemiology, Helmholtz Center for Infection Research, Braunschweig; RNA Biology of Bacterial Infections, Helmholtz Institute for RNA-Based Infection Research, Würzburg; TI Bioresources, Biodata, and Digital Health (TI BBD), German Center for Infection Research (DZIF), Braunschweig; TWINCORE, Center for Experimental and Clinical Infection Research, Hanover.

Dtsch Arztebl Int ; 118(48): 824-831, 2021 12 03.

Article em En | MEDLINE | ID: mdl-35191825

Assuntos

COVID-19; SARS-CoV-2; Alemanha/epidemiologia; Humanos; Pandemias; Estudos Soroepidemiológicos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Dtsch Arztebl Int Assunto da revista: MEDICINA / SAUDE PUBLICA Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google